Advertisement

Intravenous Fat Emulsion

[25 August 2014]

Products Affected - Description

Liposyn III emulsion (soybean oil), Hospira
10% 250 mL (NDC 00409-9790-02)
10% 500 mL (NDC 00409-9790-03)
20% 250 mL (NDC 00409-9791-02)
20% 500 mL (NDC 00409-9791-03)
30% 500 mL (NDC 00409-6892-03)

Reason for the Shortage

  • Hospira recalled several lots of Liposyn II and Liposyn III presentations.
  • Hospira has discontinued the Liposyn II presentations because the raw material is unavailable.
  • Hospira has Liposyn III on shortage due to manufacturing delays.
  • Baxter had Intralipid presentations on intermittent back order due to increased demand, but product is readily available at this time.

Available Products

Intralipid emulsion, Baxter
20% 100 mL (NDC 00338-0519-48)
20% 250 mL (NDC 00338-0519-02)
20% 500 mL (NDC 00338-0519-03)
20% 1000 mL (NDC 00338-0519-04)
30% 500 mL (NDC 00338-0520-03)

Estimated Resupply Dates

Hospira has all Liposyn III presentations on back order and the company cannot estimate a release date.

Alternative Agents & Management

The American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.) has "Information to Use in the Event of an Intravenous Fat Emulsion Shortage".

Related Shortages

Updated

August 25, 2014; June 6, 2014; May 1, 2014; March 12, 2014; February 10, 2014; February 6, 2014; December 13, 2013; October 28, 2013; September 4, 2013; August 21, 2013; August 7, 2013; July 11, 2013; June 4, 2013; May 24, 2013; March 20, 2013; February 8, 2013; December 26, 2012; December 19, 2012; December 5, 2012; November 28, 2012; October 10, 2012; August 7, 2012; May 24, 2012; March 28, 2012; February 27, 2012; January 3, 2012; December 29, 2011; October 6, 2011; August 10, 2011; July 14, 2011; June 17, 2011; May 19, 2011; April 13, 2011; March 22, 2011; February 15, 2011; January 14, 2011; November 29, 2010; October 13, 2010; September 29, 2010; August 13, 2010; July 9, 2010; June 21, 2010; June 18, 2010; May 21, 2010; April 21, 2010; March 1, 2010; January 28, 2010; December 31, 2009; December 14, 2009; November 19, 2009; October 26, 2009, University of Utah, Drug Information Service. Copyright 2014, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins

Advocacy Activity
Get the latest updates on ASHP's advocacy activity on drug shortages.
Advertisement